Total Payments
$4,745
2024 Payments
$1,035
Companies
21
Transactions
225
Medicare Patients
192
Medicare Billing
$27,067
Payment Breakdown by Category
Food & Beverage$4,745 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,745 | 225 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,948 | 78 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $763.81 | 40 | $0 (2024) |
| Alkermes, Inc. | $412.52 | 20 | $0 (2024) |
| Lundbeck LLC | $356.75 | 17 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $323.19 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $200.07 | 16 | $0 (2022) |
| ITI, Inc. | $125.07 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $114.62 | 6 | $0 (2020) |
| Allergan, Inc. | $99.06 | 6 | $0 (2020) |
| Indivior Inc. | $68.39 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,035 | 43 | ABBVIE INC. ($642.06) |
| 2023 | $1,075 | 43 | AbbVie Inc. ($548.65) |
| 2022 | $723.79 | 31 | ABBVIE INC. ($471.45) |
| 2021 | $770.77 | 37 | AbbVie Inc. ($285.41) |
| 2020 | $318.35 | 19 | Otsuka America Pharmaceutical, Inc. ($105.68) |
| 2019 | $442.03 | 25 | Otsuka America Pharmaceutical, Inc. ($205.86) |
| 2018 | $260.75 | 14 | Otsuka America Pharmaceutical, Inc. ($85.54) |
| 2017 | $119.58 | 13 | Alkermes, Inc. ($34.37) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Diagnostics | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.32 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: CNS | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: CNS | ||||||
| 08/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Neuropsychiatry | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: CNS | ||||||
| 05/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: CNS | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 59 | 152 | $18,700 | $7,587 |
| 2020 | 5 | 133 | 292 | $46,786 | $19,480 |
Total Patients
192
Total Services
444
Medicare Billing
$27,067
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 31 | 82 | $8,200 | $3,978 | 48.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 70 | $10,500 | $3,609 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 78 | $16,000 | $5,903 | 36.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 31 | 94 | $9,400 | $5,320 | 56.6% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 29 | 74 | $12,950 | $5,158 | 39.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $4,250 | $1,586 | 37.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 29 | $4,186 | $1,513 | 36.1% |
About Dr. Prudencio Samson, MD
Dr. Prudencio Samson, MD is a Psychiatry healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013045863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prudencio Samson, MD has received a total of $4,745 in payments from pharmaceutical and medical device companies, with $1,035 received in 2024. These payments were reported across 225 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,745).
As a Medicare-enrolled provider, Samson has provided services to 192 Medicare beneficiaries, totaling 444 services with total Medicare billing of $27,067. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Roseville, CA
- Active Since 03/02/2007
- Last Updated 01/23/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1013045863
Products in Payments
- VRAYLAR (Drug) $1,973
- REXULTI (Drug) $623.25
- ABILIFY MAINTENA (Drug) $328.65
- INGREZZA (Drug) $323.19
- ARISTADA (Drug) $237.72
- LATUDA (Drug) $200.07
- CAPLYTA (Drug) $148.82
- Aristada 441 mg (Drug) $111.72
- ABILIFY ASIMTUFII (Drug) $91.85
- UBRELVY (Drug) $73.37
- PERSERIS (Drug) $68.39
- INVEGA SUSTENNA (Drug) $67.41
- TRINTELLIX (Drug) $54.72
- APTIMA (Device) $49.06
- VIVITROL (Drug) $47.79
- INVEGA TRINZA (Drug) $47.21
- ABILIFY MYCITE (Drug) $38.75
- BRINTELLIX (Drug) $38.06
- Dayvigo (Drug) $36.71
- BEXSERO (Biological) $27.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Roseville
James Adamo, M.d, M.D
Psychiatry — Payments: $25,855
Psychiatry $25,855
Jonathon Porter, D.o, D.O
Psychiatry — Payments: $4,935
Psychiatry $4,935
Lorerky Ramirez-Moya, Md, MD
Psychiatry — Payments: $3,832
Psychiatry $3,832
Dr. Karla De Beck, M.d, M.D
Psychiatry — Payments: $2,982
Psychiatry $2,982
Chunlin Yang, M.d, M.D
Psychiatry — Payments: $2,557
Psychiatry $2,557
Dr. Anthony Kelada, M.d, M.D
Psychiatry — Payments: $2,481
Psychiatry $2,481